11 min listen
Dr Sarah O'Brien on the PREVAPIX-ALL trial
Dr Sarah O'Brien on the PREVAPIX-ALL trial
ratings:
Length:
14 minutes
Released:
Dec 20, 2023
Format:
Podcast episode
Description
Dr Susan O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to low-molecular-weight-heparin for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma.Read the full article:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00314-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhaeContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Dec 20, 2023
Format:
Podcast episode
Titles in the series (43)
The Lancet Haematology: December 1, 2014 by The Lancet Haematology in conversation with